CLINICAL_TRIALS
trial_result
· 2012-06-25
Clinical Trial Update: A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) [Phase 2]
Summary
Phase 2 safety and efficacy study of LymphoStat-B (belimumab) in rheumatoid arthritis completed; results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Human Genome Sciences Inc. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2012-06-25